Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System

Journal of Managed Care & Specialty Pharmacy
JaeJin AnGustavus Aranda

Abstract

Warfarin is a common treatment option to manage patients with nonvalvular atrial fibrillation (NVAF) in clinical practice. Understanding current pharmacist-led anticoagulation clinic management patterns and associated outcomes is important for quality improvement; however, currently little evidence associating outcomes with management patterns exists. To (a) describe warfarin management patterns and (b) evaluate associations between warfarin treatment and clinical outcomes for patients with NVAF in an integrated health care system. A retrospective cohort study was conducted among NVAF patients with warfarin therapy between January 1, 2006, and December 31, 2011, using Kaiser Permanente Southern California data, and followed until December 31, 2013. Management patterns related to international normalized ratio (INR) monitoring, anticoagulation clinic pharmacist intervention (consultation), and warfarin dose adjustments were investigated along with yearly attrition rates, time-in-therapeutic ranges (TTRs), and clinical outcomes (stroke or systemic embolism and major bleeding). Descriptive statistics and multivariable Cox proportional hazard models were used to determine associations between TTR and clinical outcomes. A total of 3...Continue Reading

References

Feb 11, 2005·JAMA : the Journal of the American Medical Association·Gregory W AlbersUNKNOWN SPORTIF Executive Steering Committee for the SPORTIF V Investigators
Mar 31, 2009·Journal of Managed Care Pharmacy : JMCP·William L BakerCraig I Coleman
Oct 21, 2010·Circulation. Cardiovascular Quality and Outcomes·Margaret C FangDaniel E Singer
Aug 13, 2011·The New England Journal of Medicine·Manesh R PatelUNKNOWN ROCKET AF Investigators
Aug 25, 2011·JAMA : the Journal of the American Medical Association·Harvey J MurffTheodore Speroff
Aug 25, 2011·JAMA : the Journal of the American Medical Association·Ashish K Jha
Apr 24, 2014·Journal of the American Heart Association·Jonathan P PicciniUNKNOWN ROCKET AF Investigators
May 7, 2015·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Winnie W NelsonJeffery R Schein
Jun 3, 2015·Journal of Clinical Pharmacy and Therapeutics·A StewartM Pirmohamed
Jun 26, 2015·Journal of Managed Care & Specialty Pharmacy·Christina A SpiveyJunling Wang
Oct 13, 2015·International Journal of Medical Informatics·David S CarrellMichael Von Korff

❮ Previous
Next ❯

Citations

Nov 14, 2018·Annals of Internal Medicine·David R VinsonUNKNOWN eSPEED Investigators of the KP CREST Network
Feb 23, 2020·Journal of the American Heart Association·Chengyi ZhengAdam L Sharp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.